Compare, Analyse IPCA Labs with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs MYLAN (US) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   MYLAN
EQUITY SHARE DATA
    IPCA LABS
Mar-19
MYLAN
Dec-18
IPCA LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,0423,395-   
Low Rs5901,869-   
Sales per share (Unadj.) Rs298.61,562.1-  
Earnings per share (Unadj.) Rs35.042.4-  
Cash flow per share (Unadj.) Rs49.4334.9-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs247.11,689.9-  
Shares outstanding (eoy) m126.35514.50-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.71.7 162.2%   
Avg P/E ratio x23.362.0 37.6%  
P/CF ratio (eoy) x16.57.9 210.1%  
Price / Book Value ratio x3.31.6 212.0%  
Dividend payout %8.60-   
Avg Mkt Cap Rs m103,1081,354,014 7.6%   
No. of employees `00013.435.0 38.4%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.022,963.0 12.2%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.0623.5 52.8%   
INCOME DATA
Net Sales Rs m37,732803,705 4.7%  
Other income Rs m5770-   
Total revenues Rs m38,309803,705 4.8%   
Gross profit Rs m6,901207,969 3.3%  
Depreciation Rs m1,824150,485 1.2%   
Interest Rs m18938,655 0.5%   
Profit before tax Rs m5,46518,828 29.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,042-2,995 -34.8%   
Profit after tax Rs m4,42221,824 20.3%  
Gross profit margin %18.325.9 70.7%  
Effective tax rate %19.1-15.9 -119.9%   
Net profit margin %11.72.7 431.6%  
BALANCE SHEET DATA
Current assets Rs m23,778448,788 5.3%   
Current liabilities Rs m10,975327,216 3.4%   
Net working cap to sales %33.915.1 224.3%  
Current ratio x2.21.4 158.0%  
Inventory Days Days10484 124.2%  
Debtors Days Days6693 70.6%  
Net fixed assets Rs m20,368155,906 13.1%   
Share capital Rs m253428 59.1%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,224869,462 3.6%   
Long term debt Rs m1,409938,429 0.2%   
Total assets Rs m45,5072,332,235 2.0%  
Interest coverage x30.01.5 2,014.6%   
Debt to equity ratio x01.1 4.2%  
Sales to assets ratio x0.80.3 240.6%   
Return on assets %10.12.6 390.7%  
Return on equity %14.22.5 564.2%  
Return on capital %17.33.2 544.9%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923167,010 2.9%  
From Investments Rs m-1,563-86,326 1.8%  
From Financial Activity Rs m-1,832-77,803 2.4%  
Net Cashflow Rs m1,5281,384 110.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.32 Rs / USD

Compare IPCA LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: J.B.CHEMICALS  DIVIS LABORATORIES  ALEMBIC PHARMA  GLENMARK PHARMA  NOVARTIS  



Today's Market

Indian Indices End Higher, FY21 GDP Growth Estimates, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their trading session on a positive note on Monday. At the closing bell on Monday, the BSE Sensex stood higher by 226 points.

Related Views On News

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys (The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
A Simple Test to Find out If a Stock Has 100x Potential
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

IPCA LABS SHARE PRICE


Jan 24, 2020 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 5-YR ANALYSIS

COMPARE IPCA LABS WITH

OTHER USEFUL LINKS

MARKET STATS